The Journal of Allergy and Clinical Immunology
Volume 121, Issue 4 , Pages 833-838 , April 2008

Issues in the diagnosis of α1-antitrypsin deficiency

  • Gary Rachelefsky, MD

      Affiliations

    • Executive Care Center for Asthma, Allergy, and Respiratory Diseases, UCLA Medical Center, Los Angeles, Calif
    • Corresponding Author InformationReprint requests: Gary Rachelefsky, MD, Executive Care Center for Asthma, Allergy, and Respiratory Diseases, UCLA Medical Center, 200 UCLA Medical Plaza, Suite 140-17, Los Angeles, CA 90095.
    • ,
  • D. Kyle Hogarth, MD

      Affiliations

    • Department of Medicine, Section of Pulmonary and Critical Care, University of Chicago, Chicago, Ill

Received 30 September 2007 ,Revised 22 November 2007 ,Accepted 28 December 2007.

 Disclosure of potential conflict of interest: G. Rachelefsky has consulting arrangements with AstraZeneca, CSL Behring, Schering-Plough, Merck, Medpointe, Forest Labs, Teva, and Asubiopharm and is on the speakers' bureau for AstraZeneca, Schering-Plough, Merck, Teva, and Genentech. D. K. Hogarth is on the speakers' bureau for CSL Behring, Talecris, and Baxter; has received research support from CSL Behring and Baxter; and has served as an expert witness on α1-antitrypsin.

PII: S0091-6749(08)00125-5

doi: 10.1016/j.jaci.2007.12.1183

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 4 , Pages 833-838 , April 2008

Article Tools

* Image Usage & Resolution